We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vasoactive Hormones During the Night in Patients With Obstructive Sleep Apnea and Healthy Controls.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00291993
Recruitment Status : Completed
First Posted : February 15, 2006
Last Update Posted : April 21, 2008
Sponsor:
Information provided by:
Regional Hospital Holstebro

Brief Summary:

Obstructive sleep apnea syndrome is complicated by considerable cardiovascular morbidity and mortality, at least partly due to hypertension. Nocturnal hypoxia, hypercapnia and acidosis stimulate chemoreceptors and presumably increased secretion of vasoactive hormones which might be responsible for hypertension in these patients.

The aim of this study is to measure the secretion of vasoactive hormones at night and to analyse the relationship between vasoactive hormones, oxygen saturation and the blood pressure at night.


Condition or disease Phase
Healthy Obstructive Sleep Apnea Phase 4

Study Type : Observational
Time Perspective: Prospective
Study Start Date : January 2004

Resource links provided by the National Library of Medicine

U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Male and female Age 20-65 Obstructive sleep apnea

Exclusion Criteria:

Drug or alcohol abuse Pregnancy or breast feeding Cancer Clinical signs or history of disease in the heart, lungs, kidney or endocrine organs Abnormal laboratory tests Albuminuria or glucosuria Aterial hypertension for healthy subjects


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00291993


Locations
Denmark
Department of Medical Research, Holstebro Hospital
Holstebro, Ringkoebing County, Denmark, 7500
Department of Medical Research
Holstebro, Denmark, 7500
Holstebro Hospital, Department of Medical Research
Holstebro, Denmark, 7500
Sponsors and Collaborators
Regional Hospital Holstebro
Investigators
Study Chair: Erling B Pedersen, Professor Holstebro Hospital, Department of Medical Research
Principal Investigator: Pia H Hansen, MD Holstebro Hospital, Department of Medical Research

ClinicalTrials.gov Identifier: NCT00291993     History of Changes
Other Study ID Numbers: MED.RES.HOS.2004.01.PHH
First Posted: February 15, 2006    Key Record Dates
Last Update Posted: April 21, 2008
Last Verified: April 2008

Keywords provided by Regional Hospital Holstebro:
Obstructive sleep apnea
Vasoactive hormones
Blood pressure

Additional relevant MeSH terms:
Apnea
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases